Teladoc Health has seen its share price grind lower over the years, even as it pushes new telehealth tools into hospitals and clinics. This raises a straightforward question for you as an investor: Is the current US$5.77 price properly anchored to the cash flows the business can realistically produce? Over the past 5 years the stock has fallen 95.7%, so the market has already repriced a huge amount of optimism and that reset now frames any discussion of what its future cash flows are...
🙂 Positive
😐 Neutral
☹️ Negative